Dietrich John Pauls

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Scott Kellen, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dietrich John Pauls:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. President & CEO, Director Voting Common Shares, no par value per share 68,591 $253,100 $3.69 01 Jun 2025 Direct
DiaMedica Therapeutics Inc. President & CEO, Director Voting Common Shares, no par value per share 68,591 $192,055 $2.80 01 Jun 2024 Direct
DiaMedica Therapeutics Inc. President & CEO, Director Stock Option (right to buy) 600,000 01 Jun 2025 Direct

Insider Reports Filed by Dietrich John Pauls

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 01 Jun 2025 1 $0 4 President & CEO, Director 03 Jun 2025, 16:18
DMAC DiaMedica Therapeutics Inc. 01 Jun 2024 1 $0 4 President and CEO, Director 03 Jun 2024, 16:41
DMAC DiaMedica Therapeutics Inc. 23 Jun 2023 1 +$49,997 4 President and CEO, Director 26 Jun 2023, 16:34
DMAC DiaMedica Therapeutics Inc. 01 Jun 2023 1 $0 4 President and CEO, Director 02 Jun 2023, 16:39
DMAC DiaMedica Therapeutics Inc. 16 Nov 2022 1 +$24,200 4 President and CEO, Director 16 Nov 2022, 19:56
DMAC DiaMedica Therapeutics Inc. 01 Jun 2022 1 $0 4 President and CEO, Director 02 Jun 2022, 17:06
DMAC DiaMedica Therapeutics Inc. 16 Aug 2021 1 +$15,700 4 President and CEO, Director 16 Aug 2021, 16:19
DMAC DiaMedica Therapeutics Inc. 28 Jul 2021 1 $0 4 President and CEO, Director 29 Jul 2021, 21:07